Official ESCRS | European Society of Cataract & Refractive Surgeons


Long-term clinical outcomes of micropulsed transcleral cyclophotocoagulation in open-angle glaucoma

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Glaucoma II

Venue: Poster Village: Pod 3

First Author: : B.Basarir TURKEY

Co Author(s): :    C. Altan   B. Solmaz   I. Pasaoglu   N. Alagoz   T. Yasar           

Abstract Details


The aim of this study is to describe our late outcomes with micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with the diagnosis of moderate to severe open angle glaucoma (OAG).


University of Heath Science Beyoglu Eye Training and Researh Hospital


Patients with moderate to severe OAG who underwent MP-TSCPC with 810 nm infrared diod laser (IRIDEX IQ810 Laser Systems, CA) were included in this retrospective study.  The patients received sub-tenon anestesia prior to the procedure. Laser power was set at 2000 mW  on micropulse delivery mode. MicroPulse® P3 probe was applied in a “painting” motion along the upper and lower hemisphere avoiding the 3 and 9 o’clock positions. The laser was delivered for 80 seconds to each hemisphere for a total of 160 seconds.


Five eyes of five patients were included. Three eyes had severe glaucoma. The mean baseline intraocular pressure (IOP) was 22.2±4.2 mmHg and patients were on 2.4±1.5 topical glaucoma medications. Mean IOP was reduced by 30.6% from baseline at postoperative week 6, 41% at month 12 and 31% at month 18.  Mean IOP dropped to 15.4±1.1 mmHg at sixth week, 13,0±1.1 mmHg at 12 months and 15.3±3.0 at 18 months postoperatively.  Average medication use did not changed significantly at final postop visit. There were no serious adverse events. Only one patient underwent SLT at 15th months.


Micropulsed transcleral diode laser seems to be a safe and effective treatment alternative to help lower IOP noninvasively in patients with OAG in early and also long term.

Financial Disclosure:


Back to previous